Cyclooxygenase-2 Regulates Mesenchymal Cell Differentiation into the Osteoblast Lineage and is Critically Involved in Bone Repair
Overview
Affiliations
Preclinical and clinical studies suggest a possible role for cyclooxygenases in bone repair and create concerns about the use of nonsteroidal antiinflammatory drugs in patients with skeletal injury. We utilized wild-type, COX-1(-/-), and COX-2(-/-) mice to demonstrate that COX-2 plays an essential role in both endochondral and intramembranous bone formation during skeletal repair. The healing of stabilized tibia fractures was significantly delayed in COX-2(-/-) mice compared with COX-1(-/-) and wild-type controls. The histology was characterized by a persistence of undifferentiated mesenchyme and a marked reduction in osteoblastogenesis that resulted in a high incidence of fibrous nonunion in the COX-2(-/-) mice. Similarly, intramembranous bone formation on the calvaria was reduced 60% in COX-2(-/-) mice following in vivo injection of FGF-1 compared with either COX-1(-/-) or wild-type mice. To elucidate the mechanism involved in reduced bone formation, osteoblastogenesis was studied in bone marrow stromal cell cultures obtained from COX-2(-/-) and wild-type mice. Bone nodule formation was reduced 50% in COX-2(-/-) mice. The defect in osteogenesis was completely rescued by addition of prostaglandin E2 (PGE(2)) to the cultures. In the presence of bone morphogenetic protein (BMP-2), bone nodule formation was enhanced to a similar level above that observed with PGE(2) alone in both control and COX-2(-/-) cultures, indicating that BMPs complement COX-2 deficiency and are downstream of prostaglandins. Furthermore, we found that the defect in COX-2(-/-) cultures correlated with significantly reduced levels of cbfa1 and osterix, two genes necessary for bone formation. Addition of PGE(2) rescued this defect, while BMP-2 enhanced cbfa1 and osterix in both COX-2(-/-) and wild-type cultures. Finally, the effects of these agents were additive, indicating that COX-2 is involved in maximal induction of osteogenesis. These results provide a model whereby COX-2 regulates the induction of cbfa1 and osterix to mediate normal skeletal repair.
Moon S, Kim J, Lee Y, Cho H, Choi Y, Yoon J Exp Mol Med. 2025; .
PMID: 40082672 DOI: 10.1038/s12276-025-01419-y.
Zhang J, Acosta F, Wang X, Zhao D, Zhang L, Hua R Proc Natl Acad Sci U S A. 2025; 122(7):e2412144122.
PMID: 39937859 PMC: 11848350. DOI: 10.1073/pnas.2412144122.
Targeting EP2 Receptor Improves Muscle and Bone Health in Dystrophin/Utrophin Double-Knockout Mice.
Gao X, Cui Y, Zhang G, Ruzbarsky J, Wang B, Layne J Cells. 2025; 14(2).
PMID: 39851544 PMC: 11763967. DOI: 10.3390/cells14020116.
Fujimori K, Iguchi Y, Yamashita Y, Gohda K, Teno N Molecules. 2025; 30(1.
PMID: 39795115 PMC: 11722014. DOI: 10.3390/molecules30010058.
Dankert J, Mehta D, Rodrick T, Kanshin E, Parola R, Ueberheide B Indian J Orthop. 2024; 58(12):1871-1882.
PMID: 39664353 PMC: 11628468. DOI: 10.1007/s43465-024-01284-3.